Spacer Provision

From 1st October, Liverpool CCG is to Commission the Spacer Provision Service.

The Pharmacy Quality Scheme (PQS) 2021/22 includes a Respiratory Domain which states:

  • All pharmacies must ensure that children aged 5 to 15 dispensed inhaled press and breathe pMDI for asthma have a spacer device, where appropriate, in line with NICE TA38; and
  • The pharmacy contractor must be able to evidence that pharmacy staff have identified patients with asthma or COPD, who were prescribed a new inhaler (i.e. for the first time or changed to a new inhaler device) between 1st April 2020 to 31st August 2021 but did not have their inhaler technique checked due to the COVID-19 pandemic, have since been offered an inhaler technique check as part of the catch-up NMS arrangements.

PQS requires the pharmacy to refer patients that require a spacer to their general practice for follow-up and a prescription.  To aid access to spacers for patients that are identified as needing one as part of this year’s Pharmacy Quality Scheme, Liverpool CCG will pay pharmacies a Single Activity Fee plus product reimbursement to issue one at the point of identification.  The aim is to expedite a patient receiving a spacer where necessary.

Claims will be submitted via PharmOutcomes, and this template will also enable pharmacies to send referrals to practices for under 15’s without personalized action plans.

The specification is attached.  The CCG will be in contact very shortly with a contract variation for pharmacies to complete in order to start offering this.  For multiples, this will go to head office. The service spec can be found below.

Schedule 2A Spacer Provision Service Specification